טוען...
Factor XIIIa Inhibitors as Potential Novel Drugs for Venous Thromboembolism
Human factor XIIIa (FXIIIa) is a multifunctional transglutaminase with a significant role in hemostasis. FXIIIa catalyzes the last step in the coagulation process. It stabilizes the blood clot by cross-linking the α- and γ-chains of fibrin. It also protects the newly formed clot from plasmin-mediate...
שמור ב:
| הוצא לאור ב: | Eur J Med Chem |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7513741/ https://ncbi.nlm.nih.gov/pubmed/32502864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejmech.2020.112442 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|